Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Jun-22 4:18 PM View:  | Oasheim Jared Chief Financial Officer | Cvrx, Inc. (CVRX) | 02-Jun-22 | Option Exercise | 9,585 | $0.24 | $2,271.65 | 138% 6.95K to 16.54K | |
| 26-May-22 6:13 PM View: | Nielsen Kirk G. Director | Cvrx, Inc. (CVRX) | 24-May-22 | Private Purchase | 8,070 | $5.05 | $40,751.90 | < 1% 1.7M to 1.71M | |
| 23-May-22 7:56 PM View: | Nielsen Kirk G. Director | Cvrx, Inc. (CVRX) | 23-May-22 | Purchase | 4,432 | $5.04 | $22,335.50 | < 1% 1.7M to 1.7M | |
| 23-May-22 7:56 PM View: | Nielsen Kirk G. Director | Cvrx, Inc. (CVRX) | 20-May-22 | Purchase | 13,387 | $5.04 | $67,408.90 | < 1% 1.69M to 1.7M | |
| 23-May-22 7:56 PM View: | Nielsen Kirk G. Director | Cvrx, Inc. (CVRX) | 19-May-22 | Private Purchase | 10,976 | $5.04 | $55,297.10 | < 1% 1.67M to 1.69M | |
| 02-May-22 5:34 PM View: | Nielsen Kirk G. Director | Cvrx, Inc. (CVRX) | 02-May-22 | Purchase | 41,988 | $5.97 | $250,673.00 | 3% 1.57M to 1.61M | |
| 02-May-22 5:34 PM View: | Nielsen Kirk G. Director | Cvrx, Inc. (CVRX) | 28-Apr-22 | Private Purchase | 100 | $5.97 | $597.00 | < 1% 1.57M to 1.57M | |
| 27-Apr-22 4:24 PM View: | Yared Nadim Chief Executive Officer Director | Cvrx, Inc. (CVRX) | 25-Apr-22 | Option Exercise | 6,059 | $0.24 | $1,435.98 | 15% 39.36K to 45.42K | |
| 26-Apr-22 4:17 PM View: | Brintnall John Chief Strategy Officer and Sec | Cvrx, Inc. (CVRX) | 22-Apr-22 | Option Exercise | 11,451 | $0.24 | $2,713.89 | 57% 20.08K to 31.53K | |
| 02-Mar-22 4:08 PM View: | Jain Mudit K. Director | Cvrx, Inc. (CVRX) | 28-Feb-22 | Market Purchase | 600 | $9.03 | $5,419.62 | < 1% 936.18K to 936.78K | 3% |
| 28-Feb-22 5:17 PM View: | Nielsen Kirk G. Director | Cvrx, Inc. (CVRX) | 24-Feb-22 | Private Purchase | 3,400 | $8.24 | $28,009.50 | < 1% 1.57M to 1.57M | |
| 23-Feb-22 5:36 PM View: | Nielsen Kirk G. Director | Cvrx, Inc. (CVRX) | 23-Feb-22 | Purchase | 38,200 | $8.04 | $307,143.00 | 2% 1.53M to 1.57M | |
| 23-Feb-22 5:36 PM View: | Nielsen Kirk G. Director | Cvrx, Inc. (CVRX) | 22-Feb-22 | Purchase | 40,008 | $7.94 | $317,660.00 | 3% 1.49M to 1.53M | |
| 23-Feb-22 5:36 PM View: | Nielsen Kirk G. Director | Cvrx, Inc. (CVRX) | 18-Feb-22 | Private Purchase | 26,659 | $7.92 | $211,227.00 | 2% 1.46M to 1.49M | |
| 10-Feb-22 5:21 PM View: | Bruhn-Ding Dean VP of Reg. Affairs and QA | Cvrx, Inc. (CVRX) | 08-Feb-22 | Option Exercise | 35,000 | $0.24 | $8,295.00 | 178% 19.65K to 54.65K | |
| 07-Feb-22 4:30 PM View: | Yared Nadim Chief Executive Officer Director | Cvrx, Inc. (CVRX) | 03-Feb-22 | Option Exercise | 18,690 | $0.24 | $4,429.53 | 90% 20.67K to 39.36K | |
| 20-Jan-22 6:14 PM View: | Yared Nadim Chief Executive Officer Director | Cvrx, Inc. (CVRX) | 19-Jan-22 | Gift | 10,500 | -- | -- | (34%) 31.17K to 20.67K | |
| 18-Jan-22 5:47 PM View: | Slattery Joseph P Director | Cvrx, Inc. (CVRX) | 13-Jan-22 | Option Exercise | 11,640 | $0.28 | $3,312.90 | 136% 8.55K to 20.2K | |
| 03-Jan-22 4:25 PM View: | Brintnall John Chief Strategy Officer and Sec | Cvrx, Inc. (CVRX) | 30-Dec-21 | Option Exercise | 2,550 | $0.24 | $604.35 | 15% 17.53K to 20.08K | |
| 30-Dec-21 4:13 PM View: | Yared Nadim Chief Executive Officer Director | Cvrx, Inc. (CVRX) | 28-Dec-21 | Option Exercise | 2,080 | $0.24 | $492.96 | 11% 18.59K to 20.67K | |
| 02-Dec-21 4:06 PM View: | Slattery Joseph P Director | Cvrx, Inc. (CVRX) | 30-Nov-21 | Option Exercise | 3,000 | $0.24 | $720.00 | 54% 5.55K to 8.55K | |
| 29-Nov-21 4:20 PM View: | Bruhn-Ding Dean VP of Reg. Affairs and QA | Cvrx, Inc. (CVRX) | 24-Nov-21 | Option Exercise | 14,000 | $0.24 | $3,360.00 | 248% 5.65K to 19.65K | |
| 24-Nov-21 4:19 PM View: | Yared Nadim Chief Executive Officer Director | Cvrx, Inc. (CVRX) | 22-Nov-21 | Option Exercise | 11,006 | $0.24 | $2,641.44 | 145% 7.58K to 18.59K | |
| 19-Nov-21 5:54 PM View: | Jain Mudit K. Director | Cvrx, Inc. (CVRX) | 19-Nov-21 | Market Purchase | 300 | $13.69 | $4,106.25 | < 1% 935.88K to 936.18K | 5% |
| 19-Nov-21 5:54 PM View: | Jain Mudit K. Director | Cvrx, Inc. (CVRX) | 18-Nov-21 | Market Purchase | 875 | $14.63 | $12,803.60 | < 1% 935.01K to 935.88K | (2%) |
| 07-Jul-21 4:47 PM View: | New Enterprise Associates 1... 10% Owner | Cvrx, Inc. (CVRX) | 02-Jul-21 | Conversion | 1,800,580 | -- | -- | 100% 0 to 1.8M | |
| 02-Jul-21 10:00 PM View: | Johnson & Johnson 10% Owner | Cvrx, Inc. (CVRX) | 02-Jul-21 | Conversion | 3,495,580 | -- | -- | 100% 0 to 3.5M | |
| 07-Jul-21 4:47 PM View: | Nea Partners 10 L P 10% Owner | Cvrx, Inc. (CVRX) | 02-Jul-21 | Private Purchase | 250,250 | $18.00 | $4,504,500.00 | 13% 1.95M to 2.2M | |
| 07-Jul-21 4:47 PM View: | New Enterprise Associates 1... 10% Owner | Cvrx, Inc. (CVRX) | 02-Jul-21 | Private Purchase | 225,500 | $18.00 | $4,059,000.00 | 13% 1.8M to 2.03M | |
| 06-Jul-21 10:00 PM View: | Glaxosmithkline Plc 10% Owner | Cvrx, Inc. (CVRX) | 02-Jul-21 | Conversion | 700,772 | -- | -- | 92% 764.4K to 1.47M | |
| 02-Jul-21 10:00 PM View: | Jain Mudit K. Director | Cvrx, Inc. (CVRX) | 02-Jul-21 | Private Purchase | 222,222 | $18.00 | $4,000,000.00 | 31% 712.16K to 934.38K | |
| 07-Jul-21 4:47 PM View: | Nea Partners 10 L P 10% Owner | Cvrx, Inc. (CVRX) | 02-Jul-21 | Conversion | 1,947,840 | -- | -- | 140740% 1.38K to 1.95M | |
| 06-Jul-21 10:00 PM View: | Glaxosmithkline Plc 10% Owner | Cvrx, Inc. (CVRX) | 02-Jul-21 | Private Purchase | 275,000 | $18.00 | $4,950,000.00 | 19% 1.47M to 1.74M | |
| 02-Jul-21 10:00 PM View: | Jain Mudit K. Director | Cvrx, Inc. (CVRX) | 02-Jul-21 | Conversion | 711,161 | -- | -- | 71116% 1.0K to 712.16K | |
| 02-Jul-21 10:00 PM View: | Jain Mudit K. Director | Cvrx, Inc. (CVRX) | 01-Jul-21 | Purchase | 1,000 | $25.10 | $25,100.00 | 100% 0 to 1.0K |
